The Biology and Genetics of Your Condition

To understand Hereditary Spastic Paraplegia (HSP) at its core, you have to look inside the nerve cells of the spinal cord. HSP is fundamentally a “logistics” problem within the body’s longest nerves.

The Biology: A Logistics Failure

Your brain sends signals to your legs through the corticospinal tract, which is made up of some of the longest nerve cells (neurons) in your body ^[1]. The “tail” of these nerves, called an axon, can be over three feet long.

To stay healthy, these long axons must constantly move materials (like nutrients and waste) back and forth. Think of the axon like a long factory assembly line. In HSP, a genetic mutation disrupts this process:

• Microtubule Instability: Axons have internal “tracks” called microtubules that allow materials to move. In many types of HSP, these tracks are broken or unstable ^[2].
• Organelle Dysfunction: The tiny “organs” inside the cell—like mitochondria (the power plants) and lysosomes (the waste disposal units)—cannot reach the ends of the nerves or function properly once they get there ^[3][4].
• Distal Degeneration: Because the very ends of the nerves are the farthest away from the cell’s “headquarters,” they are the first to struggle and break down. This is why symptoms almost always start in the feet and legs ^[1].

The Genetic Landscape

There is no single “HSP gene.” Instead, scientists have identified over 80 different genes that can cause the condition ^[5]. These are inherited in different ways:

• Autosomal Dominant: You only need one copy of the mutated gene (from one parent) to have the condition. This means there is a 50% chance of passing the gene to a child. The most common type is SPAST (also known as SPG4) ^[6].
• Autosomal Recessive: You need two copies of the mutated gene (one from each parent) to have the condition. This means both parents must carry the gene, and there is a 25% chance for their children to inherit the condition. The most common type is SPG11 ^[7].

Why the Names are Changing

For decades, doctors used a numbering system called SPG (for Spastic Paraplegia Gene) followed by a number (e.g., SPG4, SPG7, SPG11) to name the different types of HSP. However, the medical field is now shifting toward a gene-based naming system ^[8].

Instead of saying “I have SPG4,” your doctor might now say you have “SPAST-related HSP.” This change is important for several reasons:

1. Clarity: Using the gene name tells doctors exactly which part of the cell’s “logistics” is broken ^[9].
2. Targeted Therapy: Future treatments will likely be “precision medicines” designed to fix the specific problem caused by a single gene ^[9]. A treatment for SPAST might not work for someone with SPG11.
3. Research: Grouping patients by their gene rather than just their symptoms helps scientists design better clinical trials.

If you see both names in your medical records, don’t be confused—they are often two different ways of describing the same genetic diagnosis.

Return to Home